⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL409685 | 0.77 | — | — | |
| Dimethylamine SCHEMBL28933326 | 0.74 | GSR (0.32) | — | |
| SCHEMBL21252624 | 0.71 | — | — | |
| SCHEMBL14327880 | 0.70 | CXCR2 (0.41) | — | |
| SCHEMBL13929572 | 0.70 | ALDH1A1 (0.41) | — | |
| SCHEMBL20050249 | 0.70 | — | — | |
| SCHEMBL20194036 | 0.67 | — | — | |
| SCHEMBL21842697 | 0.67 | GAA (0.40) | — | |
| Methyl Alcohol SCHEMBL28845780 | 0.66 | GSR (0.35) | — | |
| SCHEMBL5634965 | 0.65 | GRIN2D (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 118 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3405455-B1 | 2-OXINDOLE COMPOUNDS | CHEMOCENTRYX INC (US) | 2024-02-28 | — | — | EP | disclosed |
| WO-2023239634-A2 | INHIBITORS OF BACTERIAL TYPE III SECRETION SYSTEM | MICROBIOTIX, INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| EP-4037768-B1 | NOVEL SUBSTITUTED 6,7-DIHYDRO-5H-BENZO[7]ANNULENE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THERAPEUTIC USES THEREOF | SANOFI SA (FR) | 2023-10-11 | — | — | EP | disclosed |
| US-20230270709-A1 | ANTIVIRAL PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION | CHRISTIAN-ALBRECHTS-UNIVERSITAT ZU KIEL (DE) | 2023-08-31 | — | — | US | disclosed |
| US-20230270709-A1 | ANTIVIRAL PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION | CHRISTIAN-ALBRECHTS-UNIVERSITAT ZU KIEL (DE) | 2023-08-31 | — | — | US | disclosed |
| US-11530207-B2 | Compounds for the treatment of cancer | SKYHAWK THERAPEUTICS, INC. (US) | 2022-12-20 | — | — | US | disclosed |
| US-11447452-B2 | Agonists of peroxisome proliferator-activated receptor alpha and methods of use | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2022-09-20 | — | — | US | disclosed |
| EP-3440073-B1 | KINASE INHIBITORS | OXULAR ACQUISITIONS LTD (GB) | 2022-06-08 | — | — | EP | disclosed |
| US-11337968-B2 | Phenylquinoline compositions for treatment of ocular disorders and conditions | THE BOARD OF REGENTS OF THE UNIVERSITY OF OKLAHOMA (US) | 2022-05-24 | — | — | US | disclosed |
| EP-3253745-B1 | COMPOUNDS CONTAINING CARBON-CARBON LINKER AS GPR120 AGONISTS | PIRAMAL ENTPR LTD (IN) | 2021-09-29 | — | — | EP | disclosed |
| US-20090036444-A1 | 5-5-Membered fused heterocyclic compound and use thereof as HCV polymerase inhibitor | JAPAN TOBACCO INC. (JP) | 2009-02-05 | — | — | US | disclosed |
| US-20090036444-A1 | 5-5-Membered fused heterocyclic compound and use thereof as HCV polymerase inhibitor | JAPAN TOBACCO INC. (JP) | 2009-02-05 | — | — | US | disclosed |
| US-7439258-B2 | Viral polymerase inhibitors | BOEHRINGER INGELHEIM (CANADA) LTD (CA) | 2008-10-21 | — | — | US | disclosed |
| US-7439258-B2 | Viral polymerase inhibitors | BOEHRINGER INGELHEIM (CANADA) LTD (CA) | 2008-10-21 | — | — | US | disclosed |
| EP-1891951-A1 | Viral polymerase inhibitors | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2008-02-27 | — | — | EP | disclosed |
| WO-2008009924-A2 | INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION | BIOLIPOX AB (SE) | 2008-01-24 | — | — | WO | disclosed |
| US-7294457-B2 | Direct binding assay for identifying inhibitors of HCV polymerase | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2007-11-13 | — | — | US | disclosed |
| US-7294457-B2 | Direct binding assay for identifying inhibitors of HCV polymerase | BOEHRINGER INGELHEIM (CANADA) LTD. (CA) | 2007-11-13 | — | — | US | disclosed |
| US-20070049593-A1 | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor | JAPAN TOBACCO INC. (JP) | 2007-03-01 | — | — | US | disclosed |
| US-20070049593-A1 | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor | JAPAN TOBACCO INC. (JP) | 2007-03-01 | — | — | US | disclosed |